28 JULY 2005 NEW ZEALAND GAZETTE, No. 112 2707

Health

Medicines Act 1981

Consent to the Distribution of a New Medicine

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand
of the new medicine set out in the Schedule hereto:

Schedule

Product: Aspirin
Active Ingredient: Aspirin 100mg
Dosage Form: Enteric coated tablet
New Zealand Sponsor: Multichem NZ Limited
Manufacturer: Cipla Ltd, Manufacturing Division, Kurkumbh Village, Taluka - Daund, Pune, Maharashtra, India

Dated this 21st day of July 2005.

DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).

go4827

Classification of Medicines

Pursuant to section 106 (1) of the Medicines Act 1981,
I, Don Matheson, Deputy Director-General, Public Health
Directorate, acting under delegated authority, hereby declare
the following:

1. The medicines listed in Schedule 1 to this notice are
   classified as prescription medicines.

2. The medicines listed in Schedule 2 to this notice are
   classified as restricted medicines.

3. The medicines listed in Schedule 3 to this notice are
   classified as pharmacy-only medicines.

Every reference to a medicine in this notice applies whether
the medicine is synthetic in origin or is from biological or
mineral sources.

Unless specific reference is made otherwise, every reference
applies also to medicines that are:

(a) preparations and admixtures containing any
proportion of any substance listed in the notice.

(b) salts and esters of any substance listed in the notice.

(c) preparations or extracts of biological materials listed
in the notice.

(d) salts or oxides of elements listed in the notice.

Unless specific reference is made otherwise, every reference
to a medicine applies:

(i) if the medicine is in an injection or eye preparation,
to any concentration of that medicine; and

(ii) if the medicine is not in an injection or eye
preparation, only if the concentration of the
medicine is greater than 10 milligrams per litre or
per kilogram.

Where any reference is modified by a statement of the
strength of the medicine, the strength is calculated using
the free acid, base, alcohol or element unless specifically
stated otherwise.

Schedule 1
Prescription Medicines

Acepromazine
Adalimumab
Adefovir
Adenosine; for injection
Alefacept

Amethocaine; for internal use; for external use in medicines
containing more than 10%; for ophthalmic use except
when used in practice by a registered optometrist
Amygdalin; at all strengths
Amylocaine
Aprepitant
Aripiprazole
Aristolochic acid; at all strengths
Articaine
Atazanavir
Atomoxetine
Atropa belladonna; except when specified elsewhere in the
Schedule; except in medicines containing 300 micrograms
or less of total solanaceous alkaloids per litre or per
kilogram
Atropine; except when specified elsewhere in the Schedule;
except when used as an antidote in a device designed
for self-injection; except in medicines containing 300
micrograms or less per litre or per kilogram
Atropine methonitrate
Benorylate
Benzocaine; for internal use; for external use in medicines
containing more than 10%
Benzydamine; for internal use
Bevacizumab
Bexarotene
Bortezomib
Bosentan
Butacaine
Butyl aminobenzoate; except in medicines for dermal use
containing 2% or less
Carbetocin
Ciclesonide
Cinacalcet
Cinchocaine; for ophthalmic use; for external use in
medicines containing more than 0.5%
Clindamycin
Colestyramine
Collagen; in injections or implantations for tissue
augmentation or cosmetic use
Darbepoetin